MX2012005597A - Formas cristalinas de pirazolopirimidinas sustituidas. - Google Patents
Formas cristalinas de pirazolopirimidinas sustituidas.Info
- Publication number
- MX2012005597A MX2012005597A MX2012005597A MX2012005597A MX2012005597A MX 2012005597 A MX2012005597 A MX 2012005597A MX 2012005597 A MX2012005597 A MX 2012005597A MX 2012005597 A MX2012005597 A MX 2012005597A MX 2012005597 A MX2012005597 A MX 2012005597A
- Authority
- MX
- Mexico
- Prior art keywords
- acid
- crystalline forms
- pyrazolopyrimidines
- crystal former
- disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se relaciona con cristales mixtos novedosos de pirazolopirimidinas y un formador de cristal mixto, en donde el formador de cristal mixto es un ácido carboxílico orgánico, preferentemente se selecciona del grupo de ácido gentísico, ácido succínico, y ácido xinafóico. Las pirazolopirimidinas, y en particular el compuesto A son potentes moduladores de mGluR5 y son útiles para la prevención y tratamiento de trastornos neurológicos agudos y crónicos, en particular trastornos del CNS (sistema nervioso central), que involucra excesiva excitación inducida por glutamato.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26426909P | 2009-11-25 | 2009-11-25 | |
EP09177036 | 2009-11-25 | ||
PCT/EP2010/068093 WO2011064237A1 (en) | 2009-11-25 | 2010-11-24 | Crystalline forms of substituted pyrazolopyrimidines |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2012005597A true MX2012005597A (es) | 2012-05-29 |
Family
ID=42145278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012005597A MX2012005597A (es) | 2009-11-25 | 2010-11-24 | Formas cristalinas de pirazolopirimidinas sustituidas. |
Country Status (13)
Country | Link |
---|---|
US (1) | US20120283274A1 (es) |
EP (1) | EP2504340A1 (es) |
JP (1) | JP2013512216A (es) |
KR (1) | KR20120098745A (es) |
CN (1) | CN102695709A (es) |
AR (1) | AR079143A1 (es) |
AU (1) | AU2010323209A1 (es) |
CA (1) | CA2776361A1 (es) |
IL (1) | IL218717A0 (es) |
MX (1) | MX2012005597A (es) |
RU (1) | RU2012126150A (es) |
WO (1) | WO2011064237A1 (es) |
ZA (1) | ZA201202097B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013087815A1 (en) | 2011-12-15 | 2013-06-20 | Merz Pharma Gmbh & Co. Kgaa | Liquid pharmaceutical composition containing a pyrazolopyrimidine derivative and pharmaceutical uses thereof |
WO2013087808A1 (en) | 2011-12-15 | 2013-06-20 | Merz Pharma Gmbh & Co. Kgaa | Pharmaceutical composition comprising a pyrazolopyrimidme and cyclodextrin |
BR112015019276A2 (pt) | 2013-02-19 | 2017-07-18 | Pfizer | compostos de azabenzimidazol como inibidores de isoenzimas de pde4 para o tratamento de distúrbios do snc e outros distúrbios |
US10131669B2 (en) | 2014-07-24 | 2018-11-20 | Pfizer Inc. | Pyrazolopyrimidine compounds |
DK3177624T3 (da) | 2014-08-06 | 2019-07-01 | Pfizer | Imidazopyridazinforbindelser |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2007280428B2 (en) | 2006-08-04 | 2012-04-12 | Merz Pharma Gmbh & Co. Kgaa | Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine |
ES2359447T3 (es) * | 2006-08-04 | 2011-05-23 | MERZ PHARMA GMBH & CO. KGAA | Pirazolopirimidinas sustituidas, un proceso para su preparación y su uso como medicina. |
EP2090576A1 (en) * | 2008-02-01 | 2009-08-19 | Merz Pharma GmbH & Co.KGaA | 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators |
EP2085398A1 (en) * | 2008-02-01 | 2009-08-05 | Merz Pharma GmbH & Co. KGaA | Pyrazolopyrimidines, a process for their preparation and their use as medicine |
-
2010
- 2010-11-24 US US13/508,404 patent/US20120283274A1/en not_active Abandoned
- 2010-11-24 CA CA2776361A patent/CA2776361A1/en not_active Abandoned
- 2010-11-24 MX MX2012005597A patent/MX2012005597A/es not_active Application Discontinuation
- 2010-11-24 JP JP2012540411A patent/JP2013512216A/ja active Pending
- 2010-11-24 AR ARP100104338A patent/AR079143A1/es unknown
- 2010-11-24 EP EP10784764A patent/EP2504340A1/en not_active Withdrawn
- 2010-11-24 RU RU2012126150/04A patent/RU2012126150A/ru unknown
- 2010-11-24 CN CN2010800534456A patent/CN102695709A/zh active Pending
- 2010-11-24 WO PCT/EP2010/068093 patent/WO2011064237A1/en active Application Filing
- 2010-11-24 AU AU2010323209A patent/AU2010323209A1/en not_active Abandoned
- 2010-11-24 KR KR1020127013330A patent/KR20120098745A/ko not_active Application Discontinuation
-
2012
- 2012-03-19 IL IL218717A patent/IL218717A0/en unknown
- 2012-03-22 ZA ZA2012/02097A patent/ZA201202097B/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL218717A0 (en) | 2012-06-28 |
CA2776361A1 (en) | 2011-06-03 |
EP2504340A1 (en) | 2012-10-03 |
AU2010323209A1 (en) | 2012-06-14 |
AR079143A1 (es) | 2011-12-28 |
WO2011064237A1 (en) | 2011-06-03 |
US20120283274A1 (en) | 2012-11-08 |
KR20120098745A (ko) | 2012-09-05 |
RU2012126150A (ru) | 2013-12-27 |
CN102695709A (zh) | 2012-09-26 |
JP2013512216A (ja) | 2013-04-11 |
ZA201202097B (en) | 2012-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA106692C2 (uk) | ІМІДАЗО[5,1-f][1,2,4]ТРИАЗИНИ ДЛЯ ЛІКУВАННЯ НЕВРОЛОГІЧНИХ РОЗЛАДІВ | |
WO2012042539A3 (en) | 3 -azabicyclo [3.1.0] hexane compounds useful for the treatment of cns disorders | |
IN2014KN00929A (es) | ||
EA201500175A1 (ru) | Соединения и композиции в качестве ингибиторов протеинкиназ | |
MX2012005597A (es) | Formas cristalinas de pirazolopirimidinas sustituidas. | |
SG178997A1 (en) | Substituted dihydro benzocycloalkyloxymethyl oxazolopyrimidinones, preparation and use thereof | |
WO2014152536A3 (en) | Inhibitors of leukotriene a4 hydrolase | |
CU24083B1 (es) | Derivados de oxazina útiles como inhibidores de bace para el tratamiento de trastornos neurológicos | |
WO2007081857A3 (en) | Cycloalkylamines as monoamine reuptake inhibitors | |
NO20100078L (no) | (2S,3R)-N-(2-((3-pyridinyl)metyl)-1-azabicyklo[2.2.2]oct-3-yl)benzofuran-2-karboksamid, nye saltformer og deres anvendelse | |
EA201500182A1 (ru) | 4-МЕТИЛ-2,3,5,9,9b-ПЕНТААЗАЦИКЛОПЕНТА[a]НАФТАЛИНЫ | |
TN2015000018A1 (en) | 5-ht3 receptor antagonists | |
EA201300250A1 (ru) | Оксадиазольные ингибиторы продуцирования лейкотриена | |
WO2012116050A3 (en) | Phosphorus containing compounds as protein kinase inhibitors | |
TW200800958A (en) | N-substituted-azacyclylamines as histamine-3 antagonists | |
MX2010002899A (es) | Derivados de azaciclilisoquinolinona e isoindolinona como antagonistas de la histamina-3. | |
EA201001481A1 (ru) | Производные третичного амина в качестве ингибиторов фосфодиэстеразы-4 | |
WO2009118765A3 (en) | Novel monoamine re-uptake inhibitor | |
EA201171393A1 (ru) | 7-([1,2,4]ТРИАЗОЛО[1,5α]ПИРИДИН-6-ИЛ)-4-(3,4-ДИХЛОРФЕНИЛ)-1,2,3,4-ТЕТРАГИДРОИЗОХИНОЛИН И ЕГО ПРИМЕНЕНИЕ | |
MX2012010084A (es) | Compuestos utiles para tratar transtornos neurodegenerativos. | |
MY159040A (en) | Compounds | |
EA201300389A1 (ru) | Оксадиазольные ингибиторы продуцирования лейкотриена | |
MX2015013059A (es) | Sales, co-cristales, y polimorfos de un compuesto ansiolitico. | |
WO2007013936A3 (en) | Method for treating nervous system disorders and conditions | |
EA201270610A1 (ru) | Хинуклидиновые соединения как альфа-7 лиганды ацетилхолинового рецептора |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |